Atlas Trials

The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine

Clinical trial NCT03659383 · UNKNOWN

Trial details

NCT number
NCT03659383
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2018-09-20
Primary completion
2019-02-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.